Validation of a Training Program for Patients With Alcohol Use Disorder
Validation of a Computer-based Training Program for Patients With Alcohol Use Disorder
1 other identifier
interventional
125
1 country
1
Brief Summary
This study aims to detect how the Web-based program SALIENCE affects patients with alcohol-use Disorder in terms of craving, cognitive functions and risk of relapse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 23, 2018
CompletedFirst Posted
Study publicly available on registry
December 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 29, 2025
April 1, 2025
8.5 years
October 23, 2018
April 28, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in alcohol craving
Visual Analogue Scale
directly before and after each SALIENCE session (3 SALIENCE sessions per week over 3 weeks)
Change in attentional bias
Dotprobe-Task (MacLeod, Mathews, \& Tata, 1986)
directly before and after each SALIENCE session (3 SALIENCE sessions per week over 3 weeks)
Change in alcohol interference
Alcohol Stroop Test (Brand, Leichsenring-Driessen, Beblo, Kremer, \& Driessen, 2009)
directly before and after each SALIENCE session (3 SALIENCE sessions per week over 3 weeks)
Change in approach-avoidance tendencies
Approach Avoidance Task (AAT) (R. W. Wiers et al., 2009)
directly before and after each SALIENCE session (3 SALIENCE sessions per week over 3 weeks)
Secondary Outcomes (1)
Relapse
90 days after study inclusion
Study Arms (2)
TAU
ACTIVE COMPARATORtreatment as usual
TAU plus SALIENCE
EXPERIMENTALtreatment as usual plus computer-based intervention "SALIENCE"
Interventions
3 computer-based training sessions with program "SALIENCE" per week over 3 weeks (see study description)
treatment as usual, , i.e. medically supervised detoxification treatment (i.e. medical management of withdrawal symptoms, associated physical discomfort and any co-existing disorders, etc.) as well as health education and supportive therapy sessions.
Eligibility Criteria
You may qualify if:
- age between 18 and 65
- alcohol use disorder (DSM-5)
- inpatient or part inpatient treatment
- alcohol abstinence for at least 72 hours and maximum for three weeks
- normal or correctable eyesight
- Sufficient ability to communicate with the investigators, to answer questions in oral and written form
- "Fully Informed Consent"
- "Written Informed Consent"
You may not qualify if:
- Withdrawal of the declaration of consent
- severe internistic, neurological or psychiatric comorbidities
- severe withdrawal symptoms (CIWA-R \> 7)
- alcohol-intoxication (\> 0 ‰)
- Pharmacotherapy with psychoactive substances within the last 14 days (except Clomethiazole or Benzodiazepines within the alcohol withdrawal treatment; treatment with these medications has to be completed within last 3 days)
- Axis 1 disorder according to ICD-10 and DSM 5 (except tobacco use disorder and specific phobia within the last 12 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit
Mannheim, Baden-Wurttemberg, 68159, Germany
Related Publications (1)
Weber A, Shevchenko Y, Gerhardt S, Hoffmann S, Kiefer F, Vollstadt-Klein S. Effectiveness of Reducing Craving in Alcohol Use Disorder Using a Serious Game (SALIENCE): Randomized Controlled Trial. JMIR Form Res. 2023 Nov 7;7:e42194. doi: 10.2196/42194.
PMID: 37934561DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sabine Vollstädt-Klein
ZI Mannheim
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2018
First Posted
December 5, 2018
Study Start
July 1, 2018
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 29, 2025
Record last verified: 2025-04